Leading Intensive Care Clinical Decision-Support Solution Secures New Funding and Inks Strategic Collaborations and Clients to Fuel Expansion BOSTON – January 20, 2022 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today, announced substantial business growth and expansion in 2021. The successful year for Etiometry included achieving new sales milestones,…
New partnership will enable clinical decision-support solutions to improve perioperative care BOSTON & ANN ARBOR, MI – September 9, 2021 — Etiometry, a leader in clinical decision-support software for critical care, today jointly announced a new collaboration with Terumo Cardiovascular, a global leader in cardiovascular surgery technologies and a subsidiary of Japan-based Terumo Corporation (TSE: 4543). The…
Following impressive growth in 2020, the new capital will enable Etiometry to extend use of its ICU clinical decision-support software to other hospital care settings. BOSTON – June 3, 2021 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today announced a fully subscribed $9 million Series A-3 extension raise to…
Collaborative effort will collect data within Rhode Island Hospital and The Miriam Hospital to advance clinical decision-support algorithms BOSTON, MA & PROVIDENCE, RI –Etiometry Inc. and the Brown-Lifespan Center for Digital Health (CDH) announce an agreement for joint clinical research and validation of the Etiometry Platform to collect data about the care of critically ill…
BOSTON, March 9th, 2021 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today, announced significant business growth and expansion in 2020. Clinicians in the intensive care setting rely on patients’ vital signs to monitor for unexpected health events. Etiometry’s software aggregates the information from multiple sources into one streamlined format to…
BOSTON, December 2nd, 2020 – Etiometry, the leader in clinical decision-support software for critical care, today announced it has received its 6th 510(k) clearance from the US Food and Drug Administration (FDA) adding several new features to the Etiometry Platform. Included are two significant enhancements to their previously cleared patient risk indices. These upgrades provide…
BOSTON, December 1st, 2020 – Etiometry, the leader in clinical decision-support software for critical care, has had multiple research projects accepted for presentation at the 16th Annual International Meeting of the Pediatric Cardiac Intensive Care Society (PCICS), which is being held virtually, Dec. 9-11. Etiometry’s clinical decision-support platform includes FDA-cleared risk algorithms, automatically collected comprehensive…
BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today. Advancements…